Qilu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has thirty-one approved drugs.
There is one tentative approval on QILU drugs.
Summary for Qilu
| US Patents: | 0 |
| Tradenames: | 28 |
| Ingredients: | 28 |
| NDAs: | 31 |
Drugs and US Patents for Qilu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qilu | OLANZAPINE | olanzapine | TABLET;ORAL | 204319-006 | Jan 27, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qilu Pharm Hainan | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 213106-001 | Sep 8, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qilu | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 203704-002 | Feb 1, 2016 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qilu Pharm Hainan | TADALAFIL | tadalafil | TABLET;ORAL | 210420-001 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-002 | Jun 29, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
